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excepted. A viral infection or an infection with one of 
the other pathogens was assumed in patients with at 
least a fourfold rise in antibody titers or an IgM 
response. 
Overall, evidence for a viral or atypical pathogen 
as a cause of infection was found in 28 patients (9.2%). 
A viral cause was found in 18 (5.9%). Positive serology 
for an atypical pathogen was documented 14 times in 
12 patients. Two patients had a viral and an atypical 
pathogen as the cause of their infection. In the largest 
of our studies, we could establish a correlation between 
eradication of the pathogen and clinical cure [7]. The 
rate of infection is somewhat lower than those reported 
in the past in unselected patients (type 1-3). It is 
assumed that in less severe cases (type 2/3) viruses play 
a more important role [3]. It  is remarkably lower (over 
40%) in comparison to a study by Nicholson et al [8] 
in younger patients (mean age 33 years) with asthma, 
who used new methods (polymerase chain reaction, 
PCR) to identify rhinoviruses and coronaviruses. A 
recent study by the Netherlands institute of primary 
health care (NIVEL) used this method to identify 
pathogens in influenza-like illness; in an additional 30% 
of patients, a pathogen could be identified (unpublished 
observations). We therefore conclude that the viral and 
atypical causes sought in our studies (excluding corona 
viruses and rhinoviruses) are uncommon causes of type 
1 exacerbations. However, a new study of the severest 
form of exacerbation (type 1) using P C R  as well as viral 
culture is needed. 
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In the UK, clinicians are obliged to take part in clinical 
audit, defined as the systematic critical review of the 
quality of medical care, including the procedures used 
for diagnosis and treatment, the use of resources and 
the resulting outcome. Pressures of cost containment 
and competition are intensifying the attention given 
to quality of care. Clinical microbiologists have an 
important role in the maintenance and improvement of 
the quality of patient care through their contributions 
to the diagnosis, management and prevention of 
infection. 
Historically, much emphasis has been placed on 
assurance of the quality of diagnostic activities within 
the clinical laboratory, particularly technical expertise. 
There are voluntary and compulsory arrangements to 
assess and assure the competence of the scientific and 
technical procedures carried out there. Some warn that 
there are too many [I]. Laboratories may run parallel 
internal quality assurance schemes [2-41. Periodic 
external review of a laboratory's proficiency is used 
as the basis for formal accreditation in many countries 
[5] but it covers only one aspect of the diagnostic cycle, 
albeit an important one. Accreditation and quality 
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assurance schemes focus on proficiency testing but do 
not necessarily lead to improvements in the quality of 
patient care. The emphasis on quality control within 
the laboratory at  the expense of pre- and post-analytical 
events is a cause for concern [6]. The highest levels of 
laboratory expertise and efficiency are of no benefit 
in terms of outcome for the patient if the quality of 
the sample received in the laboratory is inadequate. 
Likewise, excessive application of flawless laboratory 
proficiency may waste resources and time when the 
performance of additional work in the laboratory 
(e.g. unnecessary speciation) delays the final report or 
provides extra information of no relevance to the 
management of an individual patient [7]. In addition to 
ensuring laboratory proficiency, clinical microbiologists 
can and must influence the quality of processes outside 
the laboratory that affect the diagnosis, treatment and 
prevention of infection. The opportunity exists to col- 
laborate with all healthcare personnel to achieve this. 
Audit provides a suitable tool. 
In the care of individual patients there is a circuit 
of events and processes involved in the area of infectious 
diseases in ruling in or ruling out an infection and in 
monitoring the progress of treatment [7]. They start 
with the consideration of a differential diagnosis. 
Samples are then chosen, collected and transported to 
the laboratory, where they are assessed and then pro- 
cessed, and the results are interpreted, reported and 
communicated to the clinician. These various processes 
take place in the context of structures - the amount and 
type of resources available. The combination of the 
processes, including the decisions based upon them, 
taking place in the structures of the particular health- 
care setting result in outcomes in terms of costs, 
improvement or otherwise in the health of the patient 
and satisfaction of the users (clinician, patient and 
payer) with the microbiology service. Consideration of 
these three general areas may provide suitable starting 
points for audit [3,7,8]. 
The audit process typically begins with the defi- 
nition of standards of good practice against which 
performance can then be measured, and practice 
corrected where it falls short, followed by re-audit to 
detect improvement. It should be a continuing cycle. 
Standards may be set and agreed locally or may already 
be established by relevant expert bodies such as colleges 
and faculties. They can be used as stated or modified 
locally. Increasingly, such standards are being developed 
and promulgated, often in the form of guidelines, 
particularly those based on sound evidence. Standards 
may be modified in the light of audit findings to 
improve further the quality of patient care, and the 
audit cycle becomes an audit spiral, driving quality 
improvein en t . 
Although there are many published examples of 
audits in microbiology, most audit activity does not 
warrant publication, as it repeats work already done and 
reported [9]. Audit differs from research [lo], although 
there are common characteristics. Audit is concerned 
with the monitoring of practice against standards with 
the aim of identifying areas for improvement, whereas 
research may help define what best practice should be. 
There is a need for the collation of audit topics and 
methods to provide a resource for others. In the UK 
there are local, regional and national databases of 
audit topics. The findings of particular audits need not 
necessarily be made public; indeed, anonymity and 
confidentiality will often encourage participation in the 
audit process. 
There is a wide range of possible areas for audit in 
medical microbiology - either within the laboratory or 
outside, leading to multidisciplinary audit enconipass- 
ing medical, nursing and other healthcare professionals, 
including those in primary care 1111. Farrington has 
comprehensively reviewed the background of audit in 
clinical microbiology in the UK [8] and provides expert 
advice on practical matters and methodology, with 
suggested items for audit. Topics suitable for review 
may be chosen on the basis of their importance for the 
quality of patient care or because of the expenditure of 
resources. Published topics pertinent to clinical micro- 
biology include user satisfaction [ 12,131, sample turn- 
around times 11 4-16] and inappropriate requests, e.g. 
inappropriate urine cultures [ 17,181, mycobacterial 
culture of cerebrospinal fluid [19], testing for diarrheal 
disease in hospital [20] and requesting patterns related 
to request form design 1211. Although few of these 
were true audits, they provided starting points for 
systematic local review of practice. There has been 
much emphasis on reduction of test ordering, with the 
intent to make cost savings, although a large reduction 
in volume is required before there are savings in the 
laboratory, unless the test is very expensive [22]. (The 
converse problem of underutilization should not be 
ignored [22].) Bartlett et a1 have reviewed in some 
detail the evolving approaches to the management of 
quality in clinical microbiology [22] and provide many 
ideas for audit, from the stage of physician ordering of 
a test through to clinical use of reported information. 
Turning to consideration of pre-analytical events, 
most standard laboratory manuals give guidance on 
specimen collection, transport and processing 1231. 
However, the advice may not be available for those who 
actually collect the sample [24], and one solution has 
been the publication of guidance for clinicians, e.g. 
the series of ‘Diagnostic Microbiology Updates’ [25], 
although these are aimed primarily at those with a 
particular interest in infectious diseases. Recent topics 
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have included diarrheal illness [26], upper respiratory 
tract infections [27] and blood cultures [28]. In this 
issue of the journal (518-522), Gyssens et a1 report the 
results of an audit of the pre-analytical processes for 
samples obtained from patients in a department of 
orthopedic surgery against a local protocol based on 
published literature. Their regretful reference to the ‘no 
man’s land’ between the clinician and the laboratory is 
a challenge to clinical microbiologists to reclaim that 
territory - one filled with samples that never reached 
the laboratory and reports that never reached the 
patient’s chart. 
This is an area in which clinical microbiologists 
must take a leading role but should involve collabora- 
tion between laboratory and clinicians. Some perceive 
the laboratory as a barrier to effective patient care 
[29] and call for ‘guidelines relating to appropriate and 
effective laboratory investigation . . . agreed between 
clinicians and laboratory specialists’ [29]. Clinical micro- 
biologists must be sensitive to the requirements of 
clinical colleagues outside the laboratory, but the two 
groups must collaborate to establish standards of best 
practice and to audit actual practice against those 
standards or guidelines. Clinical medicine and labora- 
tory medicine continue to develop rapidly, and good 
communication and cooperation between the two fields 
will maintain and improve the quality of patient care. 
In summary, substantial overlap exists between 
quality management, clinical audit and evidence-based 
practice. Blomberg has called for the involvement of 
clinical pathologists in key medical staff committees, 
including those for quality assurance, peer review and 
infection control [30]. Clinical microbiologists have an 
important role in the formulation of guidelines for 
the diagnosis, management and prevention of infection 
and in the use of antibiotics [31], guidelines which 
guarantee the level of care given to patients and against 
which practice can be audited. Clinical microbiologists 
can take the lead in audit - particularly in the field of 
nosocomial infection [32-351. McGowan has warned 
that clinical microbiologists will do well to keep ahead 
of the growing number of regulatory bodies [1,22] and 
take matters of quality into their own hands. 
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